• Bone density in apheresis donors and whole blood donors

  C. L. Boot, J. S. Luken, P. J. M. van den Burg, W. L. A. M. de Kort, M. M. W. Koopman, H. Vrielink, - 2015-05-29

• Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen-HCl–UVA (Intercept™) over a 5-year period of extensive delivery

  V. Bost, P. Chavarin, F. Boussoulade, P. Fabrigli, C. Chabre, H. Benamara, H. Odent-Malaure, D. Legr - 2015-05-29

• Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis

  A. J. Szkotak, B. Lunty, S. Nahirniak and G. Clarke - 2015-05-29

• Collaborative study for the characterization of a chikungunya virus RNA reference reagent for use in nucleic acid testing

  G. Añez, Z. Jiang, D. A. R. Heisey, S. Kerby and M. Rios - 2015-05-26

• A simple genotyping procedure without DNA extraction to identify rare blood donors

  M Silvy, J-C Brès, A Grimaldi, C Movia , V Muriel, F Roubinet, J Chiaroni, P Bailly - 2015-05-18

• Unreliable patient identification warrants ABO typing at admission to check existing records before transfusion

  V Ferrera-Tourenc, B Lassale, J Chiaroni, I Dettori - 2015-05-18

• A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment

  F. Knutson, J. Osselaer, L. Pierelli, M. Lozano, J. Cid, R. Tardivel, O. Garraud, T. Hervig, D. Doma - 2015-05-15

• Donor attention to reading materials

  S. F. O'Brien, L. Osmond, K. Choquet, Q.-L. Yi and M. Goldman - 2015-05-14

• Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood

  Y. S. Loh, M. M. Dean, L. Johnson and D. C. Marks - 2015-05-14